Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 853 of 1,261
  1. US 8529257

    Aerosolized ceramic porcelains and glaze composition

    EnameLite, LLC · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  2. US 8529872

    Seeds and markers for use in imaging

    The Board of Regents of the University of Texas System · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  3. US 8529898

    Activatable binding polypeptides and methods of identification and use thereof

    The Regents of the University of California · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  4. US 8529882

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  5. US 8529885

    AAV vectors for in vivo gene therapy of rheumatoid arthritis

    ACADEMISCH MEDISCH CENTRUM · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  6. US 8529916

    High concentration baclofen preparations

    The Board of Regents of the University of Texas System · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  7. US 8530405

    Method of preparing water-soluble and biodegradable antimicrobial agent

    FAR EASTERN NEW CENTURY CORPORATION · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  8. US 8530663

    1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds

    Theravance, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  9. US 8530626

    Methods to produce keratin elastomer

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  10. US 8530675

    Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (rose bengal) and related xanthenes

    Provectus Pharmaceuticals, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  11. US 8530621

    Combined preparation of a thiazide diuretic and a loop diuretic

    The Regents of the University of California · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  12. US 8530492

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  13. US 8530466

    Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis

    Rigel Pharmaceuticals, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  14. US 8530167

    Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  15. US 8530499

    Glucokinase activators

    Takeda San Diego, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  16. AU 2013203283

    Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyophenyl)-2-methanesulfonylethylamine

    CELGENE CORP [CH] · Granted Sep 5, 2013 · Expires Aug 31, 2033

    granted
  17. US 8524214

    Polyal drug conjugates comprising variable rate-releasing linkers

    Mersana Therapeutics, Inc. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  18. US 8524655

    Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders

    Northwestern University · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  19. US 8524676

    Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds

    Sarepta Therapeutics, Inc. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  20. US 8524247

    Rabies virus-based recombinant immunocontraceptive compositions and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  21. US 8524718

    Heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  22. US 8524906

    Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  23. US 8524902

    [1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  24. US 8524910

    Pyridyl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.